Tempus AI, Inc. (TEM): Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand Tempus AI (TEM)

Tempus AI, Inc (TEM) integrates its algorithms into the operations of leading clinics and pharma behemoths. The visionary founder is actively expanding genetic data arrays despite operating losses. Scaling the AI platform is creating a foundation for a stable cash generator. The P/E and growth balance indicator reflects the current market valuation, where the metric value is 0.00, helping to determine the asset's fundamental undervaluation.

TEM: Tempus AI Inc PEG Multiple 06/15/2024 - 11/10/2026
Core merchandise of Tempus

The PEG ratio compares the P/E multiple with earnings growth rates, allowing for a determination of whether an asset's valuation is fair relative to its expansion. By analyzing the P/E-to-growth dynamics, an investor can gauge the capitalization efficiency of Tempus AI, Inc (TEM), whose value is underpinned by a unique medical dataset and the implementation of artificial intelligence in personalized diagnostics.

Competitors of Tempus AI, Inc

PEG Multiple Qiagen NV (QGEN)|Price/Earnings to Growth Ratio Ionis Pharma IONS|Growth-Adjusted Market Cap to Net Income Repligen Inc. (RGEN)|RNA: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio CRSP (crisprtx.com)|WGS: PEG Multiple|Ultragenyx Pharmaceutical Inc. (RARE) - PEG Multiple|BEAM (Beam Therapeutics Corp) - PEG Multiple|Sarepta Corp (SRPT) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple TWST (Twist Bioscience)|TXG (10xgenomics.com) - Growth-Adjusted Payback Ratio|PEG Multiple NTLA (Intellia Therapeutics, Inc.)|Growth-Adjusted Market Cap to Net Income Stoke Therapeutics Inc (STOK)|BLFS - Price/Earnings to Growth Ratio|WVE (Wave Pharma) - Growth-Adjusted P/E Ratio|MAZE: PEG Multiple|Price/Earnings to Growth Multiple sionnatx.com|Price/Earnings to Growth Multiple PRME|TSHA (Taysha Gene Therapies Inc) - Company Value to Earnings Growth Ratio|PEG Multiple QURE|MGTX - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio REGENXBIO Inc. RGNX|SLDB - Price/Earnings to Growth Multiple|Ocugen - PEG Multiple|PACB (Pacific Biosciences of California, Inc.) - Growth-Adjusted P/E Ratio|Benitec (BNTC) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio DSGN|RCKT (Rocket Pharmaceuticals) - PEG Multiple|PEG Multiple 4dmoleculartherapeutics.com|Price/Earnings to Growth Multiple LXEO (Lexeo Therapeutics)|Company Value to Earnings Growth Ratio KRRO|PEG Multiple EDIT (Editas)|Silence Therapeutics Corp (SLN) - Price to Earnings Adjusted for Growth Rate|PRQR - Price/Earnings to Growth Ratio|Codexis, Inc. (CDXS) - Price/Earnings to Growth Multiple|Sangamo Therapeutics, Inc. (SGMO) - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio NAUT (Nautilus Bio)|Price/Earnings to Growth Multiple MGX|PEG Multiple Precision BioSciences Inc.|Price/Earnings to Growth Ratio Generation Bio Co. (GBIO)|Growth-Adjusted Market Cap to Net Income boundlessbio.com|Exicure - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio IMNN|RXi Pharmaceuticals - PEG Multiple|MBIO - PEG Multiple|RNAZ: PEG Multiple|BNGO - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple APDN|BLUE: Growth-Adjusted Payback Ratio|PEG Multiple IPA|Growth-Adjusted Market Cap to Net Income Omega Therapeutics Corp|Price/Earnings to Growth Ratio Singular Genomics Systems OMIC|RGLS: Growth-Adjusted P/E Ratio|Syros Pharmaceuticals, Inc. - PEG Multiple|Telesis Bio Inc. (TBIO) - Price/Earnings to Growth Multiple|TCON (TRACON) - Price/Earnings to Growth Multiple|UBX: Company Value to Earnings Growth Ratio